Nanocan Therapeutics

Nanocan Therapeutics

Developing nanotechnology for more precise and targeted treatment of cancer and respiratory diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$5—7m (Dealroom.co estimates Aug 2020.)
Princeton New Jersey (HQ)
Authorizing premium user...